This paper is in the following e-collection/theme issue:

Structural biology and molecular modeling (2) Infectious Diseases (non-STD/STI) (1548) Theme Issue: Novel Coronavirus (COVID-19) Outbreak Rapid Reports (1507) JMIR Theme Issue: COVID-19 Special Issue (2433) Pharmacology and Pharmaceutics (60)

Published on in Vol 5 (2024)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/58018, first published .
Comparison of the Neutralization Power of Sotrovimab Against SARS-CoV-2 Variants: Development of a Rapid Computational Method

Comparison of the Neutralization Power of Sotrovimab Against SARS-CoV-2 Variants: Development of a Rapid Computational Method

Comparison of the Neutralization Power of Sotrovimab Against SARS-CoV-2 Variants: Development of a Rapid Computational Method

Authors of this article:

Dana Ashoor1 Author Orcid Image ;   Maryam Marzouq1 Author Orcid Image ;   M-Dahmani Fathallah1 Author Orcid Image
Article Authors Cited by Tweetations (1) Metrics

Dana Ashoor   1 , MSc, PhD ;   Maryam Marzouq   1 , MSc, PhD ;   M-Dahmani Fathallah   1 , MSc, MBA, DPhil, PhD

1 Department of Life Sciences, Health Biotechnology Program - King Fahad Chair for Health Biotechnology, College of Graduate Studies, Arabian Gulf University, Manama, Bahrain

Corresponding Author:

  • Dana Ashoor, MSc, PhD
  • Department of Life Sciences, Health Biotechnology Program - King Fahad Chair for Health Biotechnology
  • College of Graduate Studies
  • Arabian Gulf University
  • Road 2904 Building 293
  • Manama, 329
  • Bahrain
  • Phone: 973 17239875
  • Email: danana@agu.edu.bh